Yi Xia

4.2k total citations
165 papers, 2.5k citations indexed

About

Yi Xia is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Yi Xia has authored 165 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 116 papers in Pathology and Forensic Medicine, 76 papers in Oncology and 53 papers in Genetics. Recurrent topics in Yi Xia's work include Lymphoma Diagnosis and Treatment (114 papers), Chronic Lymphocytic Leukemia Research (51 papers) and Viral-associated cancers and disorders (46 papers). Yi Xia is often cited by papers focused on Lymphoma Diagnosis and Treatment (114 papers), Chronic Lymphocytic Leukemia Research (51 papers) and Viral-associated cancers and disorders (46 papers). Yi Xia collaborates with scholars based in China, United States and Netherlands. Yi Xia's co-authors include Zhiming Li, Panpan Liu, Yu Wang, Wei Xu, Wen-Qi Jiang, Peng Sun, Lei Fan, Jianyong Li, Huayuan Zhu and Hui-Qiang Huang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Yi Xia

158 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Xia China	29	1.1k	1.1k	760	549	505	165	2.5k
Theodoros P. Vassilakopoulos Greece	26	1.6k 1.4×	1.6k 1.4×	733 1.0×	540 1.0×	728 1.4×	167	3.1k
Tilmann Spieker Germany	25	665 0.6×	913 0.8×	547 0.7×	928 1.7×	305 0.6×	61	2.8k
Brian T. Hill United States	27	962 0.8×	1.2k 1.0×	475 0.6×	746 1.4×	790 1.6×	225	2.7k
Maria K. Angelopoulou Greece	23	869 0.8×	702 0.6×	303 0.4×	470 0.9×	693 1.4×	134	1.9k
Krzysztof Warzocha Poland	26	1.1k 1.0×	672 0.6×	857 1.1×	518 0.9×	999 2.0×	169	2.6k
Mustafa Beneklı Türkiye	24	470 0.4×	1.2k 1.1×	291 0.4×	623 1.1×	352 0.7×	182	2.6k
Roberto Giardini Italy	32	1.7k 1.5×	1.2k 1.0×	339 0.4×	661 1.2×	671 1.3×	84	3.2k
Julio Delgado Spain	35	1.3k 1.2×	1.0k 0.9×	939 1.2×	647 1.2×	1.6k 3.2×	195	3.6k
Paolo F. Caimi United States	23	948 0.8×	1.5k 1.3×	387 0.5×	467 0.9×	423 0.8×	209	2.2k
Samantha Pozzi Italy	27	700 0.6×	1.1k 1.0×	247 0.3×	853 1.6×	279 0.6×	91	2.3k

Countries citing papers authored by Yi Xia

Since Specialization

Citations

This map shows the geographic impact of Yi Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Xia more than expected).

Fields of papers citing papers by Yi Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Xia. The network helps show where Yi Xia may publish in the future.

Co-authorship network of co-authors of Yi Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Xia. A scholar is included among the top collaborators of Yi Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Xia. Yi Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jing, Qingqing Chen, Yi Xia, et al.. (2023). The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis. Journal of Clinical Immunology. 43(6). 1302–1310. 9 indexed citations

Su, Ning, Yi Cao, Yi Xia, et al.. (2023). Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial. BMC Medicine. 21(1). 423–423. 8 indexed citations

Su, Ning, Fang Yu, Shu‐Yun Ma, et al.. (2022). Comparison of Chemotherapy Combined With Chidamide Versus Chemotherapy in the Frontline Treatment for Peripheral T-Cell Lymphoma. Frontiers in Immunology. 13. 835103–835103. 13 indexed citations

Cao, Xin, Yilin Kong, Li Wang, et al.. (2021). Circulating low CD4+/CD8+ ratio is associated with poor prognosis in Waldenstrom macroglobulinemia patients. Annals of Hematology. 100(4). 995–1002. 7 indexed citations

Cai, Jun, Xiao‐Peng Tian, Shu‐Yun Ma, et al.. (2021). A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study. British Journal of Cancer. 125(3). 402–412. 11 indexed citations

Zou, Yixin, Huayuan Zhu, Yi Xia, et al.. (2019). The impacts of zanubrutinib on immune cells in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hematological Oncology. 37(4). 392–400. 43 indexed citations

Nie, Man, Linbin Yang, Xiwen Bi, et al.. (2018). Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling. Clinical Cancer Research. 25(6). 1867–1879. 206 indexed citations

Zou, Yixin, Lei Fan, Yi Xia, et al.. (2018). NOTCH1 mutation and its prognostic significance in Chinese chronic lymphocytic leukemia: a retrospective study of 317 cases. Cancer Medicine. 7(5). 1689–1696. 10 indexed citations

Fan, Lei, Jin‐Hua Liang, Robert Peter Gale, et al.. (2018). Definition of disease‐progression risk stratification in untreated chronic lymphocytic leukemia using combined clinical, molecular and virological variables. Hematological Oncology. 36(4). 656–662. 2 indexed citations

10.

Liu, Panpan, Kefeng Wang, Jietian Jin, et al.. (2018). Role of radiation therapy in primary breast diffuse large B‐cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine. 7(5). 1845–1851. 12 indexed citations

11.

Zou, Yixin, Huayuan Zhu, Ruinan Lu, et al.. (2018). Albumin-to-Fibrinogen Ratio as an Independent Prognostic Parameter in Untreated Chronic Lymphocytic Leukemia: A Retrospective Study of 191 Cases. Cancer Research and Treatment. 51(2). 664–671. 22 indexed citations

12.

Yang, Yuqiong, Tian Tian, Huayuan Zhu, et al.. (2018). NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia. BMC Cancer. 18(1). 1009–1009. 17 indexed citations

13.

Miao, Yuqing, et al.. (2017). Targeted Gene Sequencing of Adult Patients with Hemophagocytic Lymphohistiocytosis. Blood. 130. 3572–3572. 2 indexed citations

14.

Winde, Charlotte M. de, Sharon Veenbergen, Ken H. Young, et al.. (2016). Tetraspanin CD37 protects against the development of B cell lymphoma. Journal of Clinical Investigation. 126(2). 653–666. 41 indexed citations

15.

Liu, Panpan, Yi Xia, Xi-Wen Bi, et al.. (2016). Racial patterns of patients with primary mediastinal large B-cell lymphoma. Medicine. 95(27). e4054–e4054. 33 indexed citations

16.

Li, Zhiming, Hui-Qiang Huang, Zhong-Jun Xia, et al.. (2013). Prognostic Value of Interim and Posttherapy ¹⁸F-FDG PET/CT in Patients with Mature T-Cell and Natural Killer Cell Lymphomas. Journal of Nuclear Medicine. 54(4). 507–515. 28 indexed citations

17.

Xia, Yi, et al.. (2013). Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma. BMC Cancer. 13(1). 222–222. 37 indexed citations

18.

Peng, Roujun, Zhong-Yu Yuan, Yi Xia, et al.. (2011). Circulating and Tumor-Infiltrating Foxp3⁺ Regulatory T Cell Subset in Chinese Patients with Extranodal NK/T Cell Lymphoma. International Journal of Biological Sciences. 7(7). 1027–1036. 8 indexed citations

19.

Huang, Jia-Jia, Yi Xia, Wei Zhao, et al.. (2011). A novel prognostic model for extranodal natural killer/T-cell lymphoma. Medical Oncology. 29(3). 2183–2190. 22 indexed citations

20.

Peng, Roujun, et al.. (2009). Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy. Chinese Journal of Cancer. 28(12). 1304–1309. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact